Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614-Reference-Cited by-同舟云学术

Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614

Published:2004-06 Issue:2-3 Volume:494 Page:273-281
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Minoura Hideaki,Takeshita Shigeru,Ita Makoto,Hirosumi Jiro,Mabuchi Miyuki,Kawamura Ikuo,Nakajima Satoko,Nakayama Osamu,Kayakiri Hiroshi,Oku Teruo,Ohkubo-Suzuki Akiko,Fukagawa Masao,Kojo Hitoshi,Hanioka Kenichi,Yamasaki Noritsugu,Imoto Takafumi,Kobayashi Yoshinori,Mutoh Seitaro

Publisher

Elsevier BV

Subject

Pharmacology

Reference34 articles.

1. Action of novel antidiabetic thiazolidinedione, T-174, in animal models of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells;Arakawa;Br. J. Pharmacol.,1998

2. Rosiglitazone;Barman Balfour;Drugs,1999

3. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice;Berger;Endocrinology,1996

4. Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects;Berger;J. Biol. Chem.,1999

5. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-γ reverses the diabetic phenotype of the Zucker diabetic fatty rat;Brown;Diabetes,1999

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism Pharmacology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

2. Benzimidazole: A versatile scaffold for drug discovery and beyond – A comprehensive review of synthetic approaches and recent advancements in medicinal chemistry;Results in Chemistry;2023-12

3. An Insight into the Recent Synthetic Approaches of Benzimidazole Motifs Based on Divergent Substrate Scope;Mini-Reviews in Organic Chemistry;2023-06

4. Stereoselective synthesis and in-silico evaluation of C4-benzimidazolyloxyphenyl substituted trans-β-lactam derivatives as promising novel PPARγ activators;Synthetic Communications;2021-10-19

5. Nuclear Hormone Receptor Medicinal Chemistry;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26